39 related articles for article (PubMed ID: 10090777)
21. Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs.
Blakey DC; Davies DH; Dowell RI; East SJ; Burke PJ; Sharma SK; Springer CJ; Mauger AB; Melton RG
Br J Cancer; 1995 Nov; 72(5):1083-8. PubMed ID: 7577451
[TBL] [Abstract][Full Text] [Related]
22. Translating antibody directed enzyme prodrug therapy (ADEPT) and prospects for combination.
Sharma SK; Bagshawe KD
Expert Opin Biol Ther; 2017 Jan; 17(1):1-13. PubMed ID: 27737561
[TBL] [Abstract][Full Text] [Related]
23. Antibody-enzyme fusion proteins for cancer therapy.
Andrady C; Sharma SK; Chester KA
Immunotherapy; 2011 Feb; 3(2):193-211. PubMed ID: 21322759
[TBL] [Abstract][Full Text] [Related]
24. Antibody Directed Enzyme Prodrug Therapy (ADEPT): Trials and tribulations.
Sharma SK; Bagshawe KD
Adv Drug Deliv Rev; 2017 Sep; 118():2-7. PubMed ID: 28916498
[TBL] [Abstract][Full Text] [Related]
25. Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspects.
Bagshawe KD; Sharma SK; Springer CJ; Rogers GT
Ann Oncol; 1994 Dec; 5(10):879-91. PubMed ID: 7696159
[TBL] [Abstract][Full Text] [Related]
26. Comparative QSAR in toxicology: examples from teratology and cancer chemotherapy of aniline mustards.
Hansch C; Telzer BR; Zhang L
Crit Rev Toxicol; 1995; 25(1):67-89. PubMed ID: 7734060
[TBL] [Abstract][Full Text] [Related]
27. Antibody-directed enzyme prodrug therapy for cancer: its theoretical basis and application.
Bagshawe KD
Mol Med Today; 1995 Dec; 1(9):424-31. PubMed ID: 9415191
[TBL] [Abstract][Full Text] [Related]
28. Antibody-directed enzyme prodrug therapy (ADEPT).
Bagshawe KD
Adv Pharmacol; 1993; 24():99-121. PubMed ID: 8504068
[No Abstract] [Full Text] [Related]
29. Novel inhibitors of carboxypeptidase G2 (CPG2): potential use in antibody-directed enzyme prodrug therapy.
Khan TH; Eno-Amooquaye EA; Searle F; Browne PJ; Osborn HM; Burke PJ
J Med Chem; 1999 Mar; 42(6):951-6. PubMed ID: 10090777
[TBL] [Abstract][Full Text] [Related]
30. Antibody-directed enzyme prodrug therapy (ADEPT) with mustard prodrugs.
Springer CJ; Niculescu-Duvaz I
Anticancer Drug Des; 1995 Jul; 10(5):361-72. PubMed ID: 7639927
[TBL] [Abstract][Full Text] [Related]
31. Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT).
Niculescu-Duvaz I; Friedlos F; Niculescu-Duvaz D; Davies L; Springer CJ
Anticancer Drug Des; 1999 Dec; 14(6):517-38. PubMed ID: 10834273
[TBL] [Abstract][Full Text] [Related]
32. Antibody-directed enzyme prodrug therapy (ADEPT) for cancer.
Bagshawe KD
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1421-31. PubMed ID: 17069527
[TBL] [Abstract][Full Text] [Related]
33. Glutamyl hydrolase: properties and pharmacologic impact.
Galivan J; Ryan T; Rhee M; Yao R; Chave K
Semin Oncol; 1999 Apr; 26(2 Suppl 6):33-7. PubMed ID: 10598552
[TBL] [Abstract][Full Text] [Related]
34. Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy.
Moradbeygi F; Ghasemi Y; Farmani AR; Hemmati S
Biomed Pharmacother; 2023 Oct; 166():115292. PubMed ID: 37579696
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
